Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (185)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wainwright, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wainwright, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy, Vol 42, 13-28, Copyright © 1998 by The British Society for Antimicrobial Chemotherapy


REVIEWS

Photodynamic antimicrobial chemotherapy (PACT)

M Wainwright
Department of Chemistry, University of Central Lancashire, Preston, UK. M.Wainwright@UCLAN.ac.uk

Whereas the photodynamic therapy (PDT) of cancer has recently shown rapid clinical acceptance, photodynamic antimicrobial chemotherapy (PACT)--which predates the related cancer regimen--is not widely appreciated. Like PDT, PACT utilizes photosensitizers and visible or ultraviolet light in order to give a phototoxic response, normally via oxidative damage. Currently, the major use of PACT is in the disinfection of blood products, particularly for viral inactivation, although more clinically-based protocols are being developed, e.g. in the treatment of oral infection. The technique has been shown to be effective in vitro against bacteria (including drug-resistant strains), yeasts, viruses and parasites. A wide range of photosensitizers, both natural and synthetic, is available with differing physicochemical make- up and light-absorption properties. PACT is proposed as a potential, low-cost approach to the treatment of locally occurring infection.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
J. Wu, H. Xu, W. Tang, R. Kopelman, M. A. Philbert, and C. Xi
Eradication of Bacteria in Suspension and Biofilms Using Methylene Blue-Loaded Dynamic Nanoplatforms
Antimicrob. Agents Chemother., July 1, 2009; 53(7): 3042 - 3048.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
M. Maclean, S. J. MacGregor, J. G. Anderson, and G. Woolsey
Inactivation of Bacterial Pathogens following Exposure to Light from a 405-Nanometer Light-Emitting Diode Array
Appl. Envir. Microbiol., April 1, 2009; 75(7): 1932 - 1937.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
M. Giladi, Y. Porat, A. Blatt, Y. Wasserman, E. D. Kirson, E. Dekel, and Y. Palti
Microbial Growth Inhibition by Alternating Electric Fields
Antimicrob. Agents Chemother., October 1, 2008; 52(10): 3517 - 3522.
[Abstract] [Full Text] [PDF]


Home page
Br J OphthalmolHome page
Z Chen, S Xuguang, W Zhiqun, and L Ran
In vitro amoebacidal activity of photodynamic therapy on Acanthamoeba
Br J Ophthalmol, September 1, 2008; 92(9): 1283 - 1286.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
M. Sharma, L. Visai, F. Bragheri, I. Cristiani, P. K. Gupta, and P. Speziale
Toluidine Blue-Mediated Photodynamic Effects on Staphylococcal Biofilms
Antimicrob. Agents Chemother., January 1, 2008; 52(1): 299 - 305.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
Y. J. Kim and Y. C. Kim
Successful Treatment of Pityriasis Versicolor With 5-Aminolevulinic Acid Photodynamic Therapy
Arch Dermatol, September 1, 2007; 143(9): 1218 - 1220.
[Full Text] [PDF]


Home page
JDRHome page
K. Konopka and T. Goslinski
Photodynamic Therapy in Dentistry
Journal of Dental Research, August 1, 2007; 86(8): 694 - 707.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
B. B. Fuchs, G. P. Tegos, M. R. Hamblin, and E. Mylonakis
Susceptibility of Cryptococcus neoformans to Photodynamic Inactivation Is Associated with Cell Wall Integrity
Antimicrob. Agents Chemother., August 1, 2007; 51(8): 2929 - 2936.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
D. Metcalf, C. Robinson, D. Devine, and S. Wood
Enhancement of erythrosine-mediated photodynamic therapy of Streptococcus mutans biofilms by light fractionation
J. Antimicrob. Chemother., July 1, 2006; 58(1): 190 - 192.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
G. P. Tegos, M. Anbe, C. Yang, T. N. Demidova, M. Satti, P. Mroz, S. Janjua, F. Gad, and M. R. Hamblin
Protease-Stable Polycationic Photosensitizer Conjugates between Polyethyleneimine and Chlorin(e6) for Broad-Spectrum Antimicrobial Photoinactivation.
Antimicrob. Agents Chemother., April 1, 2006; 50(4): 1402 - 1410.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
S. Wood, D. Metcalf, D. Devine, and C. Robinson
Erythrosine is a potential photosensitizer for the photodynamic therapy of oral plaque biofilms
J. Antimicrob. Chemother., April 1, 2006; 57(4): 680 - 684.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
T. N. Demidova and M. R. Hamblin
Photodynamic Inactivation of Bacillus Spores, Mediated by Phenothiazinium Dyes
Appl. Envir. Microbiol., November 1, 2005; 71(11): 6918 - 6925.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
M. L. Embleton, S. P. Nair, W. Heywood, D. C. Menon, B. D. Cookson, and M. Wilson
Development of a Novel Targeting System for Lethal Photosensitization of Antibiotic-Resistant Strains of Staphylococcus aureus
Antimicrob. Agents Chemother., September 1, 2005; 49(9): 3690 - 3696.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
T. Maisch, C. Bosl, R.-M. Szeimies, N. Lehn, and C. Abels
Photodynamic Effects of Novel XF Porphyrin Derivatives on Prokaryotic and Eukaryotic Cells
Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1542 - 1552.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
T.-W. Wong, Y.-Y. Wang, H.-M. Sheu, and Y.-C. Chuang
Bactericidal Effects of Toluidine Blue-Mediated Photodynamic Action on Vibrio vulnificus
Antimicrob. Agents Chemother., March 1, 2005; 49(3): 895 - 902.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
F. Gad, T. Zahra, T. Hasan, and M. R. Hamblin
Effects of Growth Phase and Extracellular Slime on Photodynamic Inactivation of Gram-Positive Pathogenic Bacteria
Antimicrob. Agents Chemother., June 1, 2004; 48(6): 2173 - 2178.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
N. A. Romanova, L. Y. Brovko, L. Moore, E. Pometun, A. P. Savitsky, N. N. Ugarova, and M. W. Griffiths
Assessment of Photodynamic Destruction of Escherichia coli O157:H7 and Listeria monocytogenes by Using ATP Bioluminescence
Appl. Envir. Microbiol., November 1, 2003; 69(11): 6393 - 6398.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
N. Komerik, H. Nakanishi, A. J. MacRobert, B. Henderson, P. Speight, and M. Wilson
In Vivo Killing of Porphyromonas gingivalis by Toluidine Blue-Mediated Photosensitization in an Animal Model
Antimicrob. Agents Chemother., March 1, 2003; 47(3): 932 - 940.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
M. L. Embleton, S. P. Nair, B. D. Cookson, and M. Wilson
Selective lethal photosensitization of methicillin-resistant Staphylococcus aureus using an IgG-tin (IV) chlorin e6 conjugate
J. Antimicrob. Chemother., December 1, 2002; 50(6): 857 - 864.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
C. R. Rovaldi, A. Pievsky, N. A. Sole, P. M. Friden, D. M. Rothstein, and P. Spacciapoli
Photoactive Porphyrin Derivative with Broad-Spectrum Activity against Oral Pathogens In Vitro
Antimicrob. Agents Chemother., December 1, 2000; 44(12): 3364 - 3367.
[Abstract] [Full Text]


Home page
BMJHome page
R. Wise
Science, medicine, and the future: The development of new antimicrobial agents
BMJ, September 5, 1998; 317(7159): 643 - 644.
[Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.